All Programs

AMP Symposium

February 5-6, 2024 – North Bethesda, MD The Accelerating Medicines Partnership® (AMP®) Program was launched in February 2014 to bring t...

AMP Systems Biology of Inflammation

Cognitive Aging Summit IV

Biomarkers Consortium – Biomarkers for Risk Stratification and Detection of Early-Onset Preeclampsia

iRelate: Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer

Convening Experts in Oncology to Address Children’s Health (COACH)

Targeted Gene Delivery for Sickle Cell Disease

Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE)

What MRD in AML Partners Are Saying

AbbVie "AbbVie is honored to be part of the Biomarkers Consortium and offers our extensive expertise in acute myeloid leukemia (AML) ...

What Biomarkers Consortium – Bone Quality Project Partners Are Saying

AgNovos Healthcare "We are excited to hear that FDA has approved the project’s biomarker qualification plan. It is an important ste...

What Neurofilament Partners Are Saying

Alector, Inc "At Alector, we are driven to discover and develop new therapeutics that harness the brain's immune system to change the...

What Pre-competitive Analytical Validation of SV2A PET as a Biomarker of Synaptic Density Partners and Service Providers Are Saying

AbbVie At AbbVie, we are committed to helping those living with and affected by neurodegenerative diseases and recognize that advancing res...

What AMP® Heart Failure Partners and Supporters Are Saying

American Heart Association® "Moving data science and healthcare forward is at the heart of everything we do at the American Heart As...

What Mucosal Healing Partners Are Saying

What Mucosal Healing Partners Are Saying Boehringer Inglheim "Boehringer Inglheim is proud to join forces with the Foundation for ...

What AMP® CMD Partners Are Saying

Amgen "Amgen is committed to advancing cardiometabolic research to help patients living with serious disease. We are proud to partici...

What Plasma A-beta Partners Are Saying

Alzheimer’s Association "There is an urgent need for - and the Alzheimer’s Association enthusiastically supports - a simple, inex...

What NIMBLE Partners Are Saying

What partners of the Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) project are saying about the NIMBLE Letter of Intent (LOI) ...

What AMP® AIM Partners Are Saying

AbbVie "At AbbVie, we know that tackling the toughest healthcare challenges requires a dynamic and collaborative approach. We are exc...

Biomarkers Consortium – Sarcopenia 2

The FNIH Biomarkers Consortium Sarcopenia 2 project, Sarcopenia as a Valid Biomarker for Identifying Individuals at Risk of Disability, r...

Biomarkers Consortium – Clinical Evaluation and Qualification of Translational Kidney Safety Biomarkers

VCTR: New Insecticides for malaria control: Discovery Research for the identification of new chemical entities for malaria control

Overview This project completed in December 2015. New Insecticides for Malaria Control: Discovery Research for the Identification of New C...

Summit Virtual Series: 2020 National Research Summit on Care, Services, and Supports for Persons with Dementia and Their Caregivers

Overview Alzheimer’s disease (AD) and related dementias continue to grow at an overwhelming rate in the Unites States. Recent estimates i...